https://doi.org/10.5812/jjhs.116516

Dioxins Exposure and the Risk of Breast Cancer: A Systematic Review and Meta-analysis

authors:

avatar Nematollah Jaafarzadeh Haghighi ORCID 1 , 2 , avatar Amal Saki Malehi ORCID 3 , avatar Zeinab Ghaedrahmat 4 , *

Environmental Technologies Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Department of Environmental Health Engineering, School of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Department of Biostatistics and Epidemiology, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Department of Environmental Health Engineering, Shoushtar faculty of Medical Sciences, Shoushtar, Iran
Jundishapur Journal of Health Sciences: Vol.13, issue 2; e116516
published online: August 3, 2021
article type: Systematic Review
received: May 29, 2021
revised: June 26, 2021
accepted: June 29, 2021

How To Cite Jaafarzadeh Haghighi N, Saki Malehi A, Ghaedrahmat Z. Dioxins Exposure and the Risk of Breast Cancer: A Systematic Review and Meta-analysis. Jundishapur J Health Sci. 2021;13(2):e116516. https://doi.org/10.5812/jjhs.116516.

Abstract

Context:

Dioxins and dioxin-like chemicals composed of 419 compounds are a large group of compounds, including polychlorinated di-benzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and biphenyls (PCBs). Dioxins are extremely persistent in the environment and disperse in a great distance from the emission source, and bioaccumulation in the food chain is one of their critical properties. The incidence of breast cancer among Iranian women is about 30 to 35 per 100,000 cases. The present study is a systematic review of published studies in English language to discover the relationship between exposure to dioxin compounds and breast cancer.

Methods:

We conducted a comprehensive literature review utilizing PubMed, Embase, Scopus, and ISI web of science databases. The MeSH-based keywords used included Organic Chemical (MeSH) OR Dioxins (MeSH) AND cancer (MeSH) OR Breast cancer (MeSH) AND Breast disease (MeSH).

Results:

The review of the literature indicated a significant positive association between dioxins exposure and the risk of breast cancer. Only in one study, breast cancer mortality rate was reported in terms of exposure to dioxins, and standardized mortality rates (SMRs) were determined.

Conclusions:

Although there were limitations in this study, statistical analyses in various epidemiological studies demonstrated that dioxins exposure is linked to an increased risk of breast cancer.

1. Context

Currently, 210 recognized dioxins (75 PCDDs and 135 PCDFs) have been recognized by the amount and location of chlorine molecules. Among them, 17 (7 PCDDs and 10 PCDFs) have been distinguished as harmful by the World Health Organization (WHO), and TCDD is the foremost harmful congener. In 1997, IARC classified TCDD as carcinogenic to humans. This classification was confirmed in 2009, with adequate population testing for all cancers, and restricted testing for lung cancer, soft tissue sarcoma, and non-lymphoma (1, 2). TCDD is not specifically genotoxic but may cause an increment in responsive oxygen species (ROS), and consequently, DNA harm and changes (3).

Previous studies have proposed that dioxins disturb estrogenic directions to the AhR and can have different impacts according to level of hormone (4-7). Dioxins demonstrate anti-estrogenic reactions within the proximity of estrogens through restraining estrogen-induced qualities and proteins (8, 9) and estrogenic impacts in the nonattendance of estrogens, through which dioxins actuate the translation of hormone-dependent qualities (9).

TCDD may be an organic pollutant (POP) (10) and bio-accumulate in animal and human nourishment systems. TCDD has more dissolvability in water, but it is exceedingly lipophilic and amasses in fat tissues. TCDD is identified in fat tissues, blood, and breast secretions (11, 12). Human exposure to dioxins is calculated based on noxious comparability leftovers (TEQ). All the 17 harmful dioxin congeners are given a harmful proportionality figure (TEF), according to its favoritism with the Alright recipient, this is weighted for the most part to TCDD. The TEQ of a mixture of congeners is calculated by multiplying individual levels of congeners by its TEF and summing the individual values. Dioxins are produced unintentionally during combustion processes involving a chlorine source such as incineration sources, cement kilns, wood-burning including domestic heating, diesel vehicles, coal-fired utilities, and crematoria, pulp, and paper mills, chemical manufacturing, and metal industry (13).

Dioxins are omnipresent contaminants within the environment, including surface water, groundwater, soil, and sediment. Dioxin exposure within the common populace is evaluated to be low; a survey assessed the TCDD blood concentration at 1.8 pg/g lipid (standard deviation SD = 1.7) within the common populace not directly exposed to dioxin emitting sources (109 studies published in 1989 - 2010 (14). IARC reported that around 90% of dioxin introduction within the common populace happens through the swallowing of sullied nourishment, due to the accumulation of them within the nourishment chain and in nourishments such as high-fat dairy items, eggs, and fats and fish (IARC 2012c).

Indeed, higher exposures happen due to mechanical mishaps, the most important of which I the blast of ICMESA chemical plant in Seveso (Italy, July 1976), causing the discharge of an expansive sum of TCDD of up to 30 kg over 18.1 km2 within the polluted zone (15). Due to their potential carcinogenicity and estrogen-mimicking properties demonstrated in experimental studies, dioxins are suspected of causing breast cancer (16, 17). This is a systematic review with emphasis on English-language published studies to discover the relationship between exposure to dioxin-related compounds and breast cancer.

The incidence of breast cancer among Iranian women is about 30 to 35 cases per 100,000. This is a systematic review of published studies in English language to discover the relationship between exposure to dioxin-related compounds and breast cancer.

2. Methods

2.1. Data Source

For this systematic literature review, we searched PubMed, Scopus, Web of Science, EMBASE, and Cochrane library databases for articles published from April 1968 to April 2020. The keywords used (MeSH) included Organic Chemical (MeSH) OR Dioxins (MeSH) AND cancer (MeSH) OR Breast Neoplasm (MeSH) AND Breast disease (MeSH). All English published articles that reported breast cancer due to exposure to dioxins were used in this study. The inclusion criteria in this study were as follows: (I) cohort studies and case-control studies; (II) human subject research; and (III) studies with the confirmation of carcinogenicity.

The exclusion criteria were as follows: (I) case reports, (II) news, (III) letters, (IV) review articles, and (V) abstracts without full texts because of the limited data. For studies with multiple results, only data on adverse outcomes was analyzed. Moreover, we focused on human health and studies whose full text was available free of charge or online through institutional subscriptions.

2.2. Data Extraction

Data extraction was conducted independently by two researchers. The endpoints of this study were all breast cancer incidences and mortalities due to the various forms of exposure to dioxins as most of the included studies adopted. The information extracted from each study included author's name, title, year of publication, population size of the study group, study area, and study results. In the process of data extraction, any disagreement between the researchers was resolved by unanimity. This meta-analysis was designed and conducted according to the PRISMA statement (Figure 1) (18).

The flow diagram for selecting studies
The flow diagram for selecting studies
Figure 1.

The flow diagram for selecting studies

2.3. Data Synthesis and Statistical Analysis

The incidence rate of breast cancer was independently estimated in cohort studies. The odds ratios (OR) and 95% confidence intervals (CI) were calculated for case-control studies. We used the Cochrane Q and I2 statistics to assess heterogeneity and inconsistency, respectively. Furthermore, funnel plot supported with Egger’s regression test was performed to assessed small-study effects. No planned subgroup analysis was performed because of the small number of studies and insufficient reported data. STATA12 software (STATA Corporation, College Station, Texas) was used for statistical analysis. A P-value of less than 0.05 was considered statistically significant.

3. Results

3.1. Study Description

After a comprehensive search, 416 articles were retrieved, 316 of which were excluded because the titles were irrelevant, 62 articles were excluded for being duplicates, and 17 articles were excluded for being review articles. Overall, 38 articles were included for further consideration, 28 of which were excluded after full review. Finally, this systematic review study included nine studied for further analysis, including four cohort studies, three case-control studies, and two cross-sectional studies.

Of the nine studies, two were performed in the USA, three in France, two in Germany, one in Italy, and one in Taiwan (19-28). There were different dioxin exposure sources, such as occupational and non-occupational exposure and industrial explosion. The general characteristics of the selected studies are presented in Table 1. Among the included studies, eight investigated the association between exposure to dioxins and the risk of breast cancer incidence, and one study evaluated breast cancer mortality.

Table 1.

Summary of the Selected Studies for the Systematic Review

ReferencesStudy PopulationBreast Cancer CasesNumber of CasesWays of ExposureP-ValuesStandardized Ratios (SMRs)Odd Ratio (95% Confidence Interval)Crude Hazard Ratio (95% CI)TEQType of StudyFinding
Dai and Oyana (24), 2008Michigan, USAFemale4,604Soil< 0.0001-1 - 2.45 --Ecological studyThe odds ratio also points to a statistically significant (= 0.05) increase in breast cancer rates as women age, as well as a higher disease burden in the Midland and the neighboring areas, which are adjacent to dioxin-polluted areas.
Viel et al. (25), 2008FranceFemale434Non-occupational exposure0.17 - 0.21-0.88 - 1.06 for women aged 20 - 59 years 0.31 - 1 for women aged 60 years and over-Case-control studyThere was not an increase or decrease in the risk of dioxin exposure among women under 60 years of old. women over 60 years old who lived in the most exposed zone, on the other hand, were 0.31 times less likely to develop invasive breast cancer (95% confidence interval, 0.08 - 0.89).
Warner et al. (26), 2002Seveso, ItalySeveso Women’s Health study981Industrial explosion0.05 - 0.07--2.1 - 3.3-Cohort studyThe hazard ratio for breast cancer was linked with a 10-fold increase in serum TCDD levels. log10 TCDD was dramatically enhanced to 2.1 (95% confidence interval, 1.0 - 4.6) using Cox proportional hazards models.
Wang et al. (27), 2006TaiwanFemale 25 - 34 years50Non-occupational exposure---4.84 - 5.97Cohort studyThe presence of PCDDs/PCDFs in the body may be linked to altered estrogen catabolism. Our findings imply that PCDD/PCDF exposure has a considerable impact on estrogen metabolism. As a result, when employing the OH-E2 ratio as a breast cancer marker, PCDD/PCDF exposure must be taken into account.
Danjou et al. (19), 2015FranceFemale63,830Dietary dioxin exposure0.0463--0.45 - 0.96-Cohort studyIn general, no link was established to estimate the relationship between dietary dioxin exposure and breast cancer risk in E3N women. To see if low-dose dioxin exposure is linked to BC risk, more research should be done on both dietary and environmental exposures.
Reynolds et al. (20), 2005California, USAFemale79Non-occaptional exposure0.36-0.47 - 3.16 for second tertiles 0.64 - 4.12 for third tertiles-Case-control studyThe presence of PCDD/PCDFs in adipose tissue was not linked to the risk of breast cancer. More research is needed among women of color, who may have larger quantities of these chemicals in their bodies.
Manuwald et al. (21), 2012Hamburg, GermanyFemale and male(1191 men/398 womenOccupational exposure-1.21 to 1.56---Cohort studyBreast cancer mortality (ICD-9 174) increased in women (SMR14.186, 95% CI 1.12 to 2.91).
Korner et al. (22),1994GermanyMammary carcinoma tissue8Non-occupational exposure-Ecological studyDespite having comparable congener profiles, the concentrations in four axillary adipose tissue samples that corresponded to cancer samples were almost 40% lower.
Villeneuve et al. (23), 2010FranceFemale and male104 cases and 1901 controlsOccupational exposure0.14-1.0 - 4.4--Case-control studyThe increased incidence of male breast cancer in particular vocations revealed probable mammary carcinogens in the environment.

3.2. Dioxin Exposure and Breast Cancer

The effects of dioxins on the incidence of breast cancer were investigated in the USA, France, and Germany. The most frequently reported result was the association of breast cancer incidence and mortality with dioxins exposure. Some articles categorized the results by gender (Table 1).

In a study in Midland, Saginaw, and Bay counties, Michigan, USA, high levels of dioxin contamination were found in the 100-year-old Midland floodplain and the Titabawasi River and, which showed a significant relationship with high incidence rates of breast cancer in Midland and polluted areas. In another study in Germany, concentration and profile of PCDDs and PCDFs in mammary carcinoma tissues were investigated.

3.3. Case-Control studies

Case-control studies were conducted to evaluate the link between dioxin exposure and breast cancer incidence (20, 23, 25). There were three case-control studies with a non-significant heterogeneity between studies (χ2 = 5.74, P = 0.057; Figure 2). However, because of substantial I2 = 65.1%, the Der Simonian and Laird’s method was applied as a random-effect model for appraising the overall OR (Figure 3). The obtained pooled OR = 1.03 (95% CI (0.57 - 1.86), P = 0.93) was non-significant. In addition, Egger’s test indicated that publication bias might not have a significant influence on the pooled estimation (P = 0.37).

Forest plot for the association between dioxins exposure and breast cancer in the case-control studies
Forest plot for the association between dioxins exposure and breast cancer in the case-control studies
Figure 2.

Forest plot for the association between dioxins exposure and breast cancer in the case-control studies

Funnel plot for dioxins exposure and breast cancer (funnel histogram with false 95% confidence limits) in the case-control studies
Funnel plot for dioxins exposure and breast cancer (funnel histogram with false 95% confidence limits) in the case-control studies
Figure 3.

Funnel plot for dioxins exposure and breast cancer (funnel histogram with false 95% confidence limits) in the case-control studies

In the study of Veil et al. (25), the association between dioxins and breast cancer risk was reported. Breast cancer cases, which were extracted from Doubs cancer registry, were women diagnosed from 1996 to 2002, aged 20 and above, and residing in the study area at the time of diagnosis. In France, among women under 60 years of age, no breast cancer risk was found for any dioxin exposure, and women aged over 60 years living in dioxin exposed areas were 0.31 times less likely (95% confidence interval, 0.08 - 0.89) to have an increased breast cancer risk (25). Another case-control study in the San Francisco Bay Area, was conducted among 79 women with invasive breast cancer and 52 controls with benign breast disease. This study determined the levels of organochlorines measured in the breast adipose tissue of women undergoing surgical breast biopsy (20). In another case-control study in eight European countries, 104 cases and 1901 controls were observed. This multi-center case-control study determined the occupational risk factors for male breast cancer (23).

3.4. Cohort Studies

Cohort studies have been conducted to evaluate the relationship between dioxins exposure and breast cancer in Italy, France, Germany, and Taiwan (19, 21, 26, 27). The association between dioxins exposure and breast cancer is shown in Table 2. In Italy, 981 breast cancer cases, in France 63830 cases, and in Germany 1191 men and 398 women with breast cancer were observed (19, 21, 26).

Table 2.

Cohort and Case-Control Studies of Dioxins and Breast Cancer

ReferenceNumber of Cases and ControlRisk Estimate (95% CI)DesignOutcomeAdjustment FactorsAge Range, y
Viel et al. (25), 2008453/2170OR: 0.88 - 1 for aged 20 - 59 years OR: 0.31 - 1 for aged 60 years and overCase-controlIncidenceAge and sex20 - 59 and 60 and over
Warner et al. (26), 2002981HR: 1 - 4.6CohortIncidenceAge and sex0 - 40
Danjou et al. (19), 201563,830HR: 0.45 - 0.96CohortincidenceAge and sex50
Reynolds et al. (20), 200579/52OR: 0.47 - 3.16 for second tertiles; OR: 0.64 - 4.12 for third tertilesCase-controlIncidenceAge and sex< 40 to > 60
Manuwald et al. (21), 20121191 men/398 womenSMRs: 1.21 - 1.56CohortMortalitySex-
Villeneuve et al. (23), 2010104/1901OR: 1.0 - 4.4Case-controlIncidenceAge< 40 to > 65
Wang et al. (27), 200650TEQ: 4.84 - 5.97CohortIncidenceAge and sex25 - 34

In Taiwan, 50 pregnant women 25 - 34 years of age were investigated for the risk of breast cancer (27). For men, overall mortality (ICD9 1999) (SMR: 1.14, 95% CI: 1.06 to 1.23), increased cancer mortality (SMR: 1.37, 95% CI: 1, 21 to 1.56). For women, breast cancer mortality increased (ICD9 174) (SMR: 1.86, 95% CI: 1.12 to 2.91 (21). The Cox proportional hazards model indicated that the breast cancer risk ratio (log10 TCDD) related to elevated serum TCDD levels raised to 2.1 (95% confidence interval, 1.0 - 4.6) (26).

The pooled estimation of incidence was 7% (95% CI (1%-16%), P < 0.001). However, there was substantial heterogeneity between studies (I2 = 99.4%, χ2 = 592.4, P < 0.001; Figures 4 and 5). A sensitivity analysis excluding the study by Wang et al. (27) had a minimal effect on the heterogeneity between studies (I2 = 98.9%, χ2 = 197.5, P < 0.001). The Egger test was also used to evaluate the effectiveness of small studies. The results indicated that publication bias might not have a significant influence on incidence rate pooled estimation (P = 0.68).

Forest plot for the association between dioxins exposure and breast cancer in cohort studies
Forest plot for the association between dioxins exposure and breast cancer in cohort studies
Figure 4.

Forest plot for the association between dioxins exposure and breast cancer in cohort studies

Funnel plot for dioxin exposure and breast cancer (funnel chart with pseudo 95% confidence limits) in case-control studies
Funnel plot for dioxin exposure and breast cancer (funnel chart with pseudo 95% confidence limits) in case-control studies
Figure 5.

Funnel plot for dioxin exposure and breast cancer (funnel chart with pseudo 95% confidence limits) in case-control studies

4. Discussion

Various studies have shown that exposure to chemicals is associated with the risk of breast cancer. Spatial grouping of breast cancer morbidity near polluted areas proposes that there are significant factors contributing to the burden of disease in women that should be considered further in future works (24). In recent years, special attention has been paid to the carcinogenic effect of pseudo-estrogen compounds such as dioxins in carcinogens on various organs including the breast (20, 23, 29). So far, the studies of dioxins in soil have shown that breast cancer incidence is specifically related to soil contamination by dioxins (24).

This meta-analysis summarized the results of four cohort studies, three case-control studies, and two cross-sectional studies = conducted on the relationship between dioxins and breast cancer incidence and mortality. Reports of Macon and Fenton (29), Viel et al. (25), Warner et al. (26), Wang et al. (27), Danjou et al. (19), Reynolds et al. (20), Korner et al. (22), Villeneuve et al. (23), and Danjou et al. (28) indicated a significant positive association between dioxins exposure and breast cancer risk. Only in one study, breast cancer mortality rates were reported in terms of exposure to dioxins and standardized mortality rates (SMRs) were determined (21). Although there were few cases, but the low P-values showed that these findings were not accidental. The results of these studies showed that individuals exposed to dioxins through a variety of sources are at a significantly increased risk of breast cancer. Findings of the present study confirmed the carcinogenicity of dioxin compounds in previous studies. In addition, these studies draw researchers' attention to the risk of breast cancer mortality in exposed individuals.

Based on the results of these studies, the risk of breast cancer mortality in women is higher than in men (ICD-9 174) (SMR = 1.86, 95% CI 1.12 to 2.91). For men, the risk of cancer mortality had increased (21). The risk of breast cancer in male vehicle mechanics due to occupational exposure to dioxins was increased (OR = 2.1, 95% CI 1.0 to 4.4) (23). Based on the results of this meta-analysis, no relationship exists between dietary dioxin exposure and breast cancer risk in women. Future works should address both dietary and environmental exposures to investigate whether dioxin exposure is related to the risk of breast cancer (19).

There are some limitations to this review that need to be addressed. The included studies were limited to peer-reviewed published articles in English. The English language criterion could have led to the selection of extensive research performed in English-speaking countries, including the United States, Canada, the United Kingdom, and Australia. By restricting the search to studies that specifically focus on breast cancer, we may have missed studies with the a more general title “cancer” in the headline review. However, the references of the included articles were also searched to minimize the possibility of omissions in a large number of studies.

5. Conclusions

This meta-analysis included nine studied including four cohort study, three case-control studies, and two cross sectional studies. These studies were conducted in different geographical locations such as Taiwan, USA, France, and Germany. Most of the studies were cohort and case-control studies. Reports of various studies indicated a significant positive association between dioxin exposure and the risk of breast cancer. Only in one study, breast cancer mortality rates were reported in terms of exposure to dioxins and standardized mortality rates (SMRs) were determined.

References

  • 1.

    Baan R, Grosse Y, Straif K, Secretan B, El Ghissassi F, Bouvard V, et al. A review of human carcinogens--Part F: chemical agents and related occupations. Lancet Oncol. 2009;10(12):1143-4. [PubMed ID: 19998521]. https://doi.org/10.1016/s1470-2045(09)70358-4.

  • 2.

    International Agency for Research on Cancer. Polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans. IARC monographs on the evaluation of carcinogenic risks to humans. 1997. 10 p.

  • 3.

    Mandal PK. Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology. J Comp Physiol B. 2005;175(4):221-30. [PubMed ID: 15900503]. https://doi.org/10.1007/s00360-005-0483-3.

  • 4.

    Brunnberg S, Andersson P, Poellinger L, Hanberg A. The constitutively active Ah receptor (CA-AhR) mouse as a model for dioxin exposure - effects in reproductive organs. Chemosphere. 2011;85(11):1701-6. [PubMed ID: 22014662]. https://doi.org/10.1016/j.chemosphere.2011.09.015.

  • 5.

    M Hall J. The Aryl-hydrocarbon Receptor (AhR) as a Therapeutic Target in Human Breast Cancer. J Steroids Hormon Sci. 2013;5(3). https://doi.org/10.4172/2157-7536.1000140.

  • 6.

    Safe S, Lee SO, Jin UH. Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target. Toxicol Sci. 2013;135(1):1-16. [PubMed ID: 23771949]. [PubMed Central ID: PMC3748760]. https://doi.org/10.1093/toxsci/kft128.

  • 7.

    Soto AM, Sonnenschein C. Environmental causes of cancer: endocrine disruptors as carcinogens. Nat Rev Endocrinol. 2010;6(7):363-70. [PubMed ID: 20498677]. [PubMed Central ID: PMC3933258]. https://doi.org/10.1038/nrendo.2010.87.

  • 8.

    Treich I, Cairns BR, de los Santos T, Brewster E, Carlson M. SNF11, a new component of the yeast SNF-SWI complex that interacts with a conserved region of SNF2. Mol Cell Biol. 1995;15(8):4240-8. [PubMed ID: 7623818]. [PubMed Central ID: PMC230663]. https://doi.org/10.1128/MCB.15.8.4240.

  • 9.

    Ohtake F, Takeyama K, Matsumoto T, Kitagawa H, Yamamoto Y, Nohara K, et al. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature. 2003;423(6939):545-50. [PubMed ID: 12774124]. https://doi.org/10.1038/nature01606.

  • 10.

    Milbrath MO, Wenger Y, Chang CW, Emond C, Garabrant D, Gillespie BW, et al. Apparent half-lives of dioxins, furans, and polychlorinated biphenyls as a function of age, body fat, smoking status, and breast-feeding. Environ Health Perspect. 2009;117(3):417-25. [PubMed ID: 19337517]. [PubMed Central ID: PMC2661912]. https://doi.org/10.1289/ehp.11781.

  • 11.

    Arisawa K, Matsumura T, Tohyama C, Saito H, Satoh H, Nagai M, et al. Fish intake, plasma omega-3 polyunsaturated fatty acids, and polychlorinated dibenzo-p-dioxins/polychlorinated dibenzo-furans and co-planar polychlorinated biphenyls in the blood of the Japanese population. Int Arch Occup Environ Health. 2003;76(3):205-15. [PubMed ID: 12690495]. https://doi.org/10.1007/s00420-002-0400-y.

  • 12.

    Sonawane BR. Chemical contaminants in human milk: an overview. Environ Health Perspect. 1995;103 Suppl 6:197-205. [PubMed ID: 8549474]. [PubMed Central ID: PMC1518901]. https://doi.org/10.1289/ehp.95103s6197.

  • 13.

    Papillomaviruses H. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon, France: IARC; 2011.

  • 14.

    Consonni D, Sindaco R, Bertazzi PA. Blood levels of dioxins, furans, dioxin-like PCBs, and TEQs in general populations: a review, 1989-2010. Environ Int. 2012;44:151-62. [PubMed ID: 22364893]. https://doi.org/10.1016/j.envint.2012.01.004.

  • 15.

    di Domenico A, Cerlesi S, Ratti S. A two-exponential model to describe the vanishing trend of 2,3,7,8-tetrachlorodibenzodioxin (TCDD) in the soil at Seveso, northern Italy. Chemosphere. 1990;20(10-12):1559-66. https://doi.org/10.1016/0045-6535(90)90313-i.

  • 16.

    Brody JG, Moysich KB, Humblet O, Attfield KR, Beehler GP, Rudel RA. Environmental pollutants and breast cancer: epidemiologic studies. Cancer. 2007;109(12 Suppl):2667-711. [PubMed ID: 17503436]. https://doi.org/10.1002/cncr.22655.

  • 17.

    Kogevinas M. Human health effects of dioxins: cancer, reproductive and endocrine system effects. Apmis. 2001;109(S103):S223-32. https://doi.org/10.1111/j.1600-0463.2001.tb05771.x.

  • 18.

    Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7). e1000097. [PubMed ID: 19621072]. [PubMed Central ID: PMC2707599]. https://doi.org/10.1371/journal.pmed.1000097.

  • 19.

    Danjou AM, Fervers B, Boutron-Ruault M, Philip T, Clavel-Chapelon F, Dossus L. Estimated dietary dioxin exposure and breast cancer risk among women from the French E3N prospective cohort. Breast Cancer Res. 2015;17(1). https://doi.org/10.1186/s13058-015-0536-9.

  • 20.

    Reynolds P, Hurley SE, Petreas M, Goldberg DE, Smith D, Gilliss D, et al. Adipose levels of dioxins and risk of breast cancer. Cancer Causes Control. 2005;16(5):525-35. [PubMed ID: 15986107]. https://doi.org/10.1007/s10552-004-7840-5.

  • 21.

    Manuwald U, Velasco Garrido M, Berger J, Manz A, Baur X. Mortality study of chemical workers exposed to dioxins: follow-up 23 years after chemical plant closure. Occup Environ Med. 2012;69(9):636-42. [PubMed ID: 22767868]. https://doi.org/10.1136/oemed-2012-100682.

  • 22.

    Korner W, Hanf V, Faust A, Temmen R, Tinneberg HR, Hagenmaier H. Concentrations and profiles of PCDDs and PCDFs in human mammary carcinoma tissue. Chemosphere. 1994;29(9-11):2339-47. [PubMed ID: 7850382]. https://doi.org/10.1016/0045-6535(94)90402-2.

  • 23.

    Villeneuve S, Cyr D, Lynge E, Orsi L, Sabroe S, Merletti F, et al. Occupation and occupational exposure to endocrine disrupting chemicals in male breast cancer: a case-control study in Europe. Occup Environ Med. 2010;67(12):837-44. [PubMed ID: 20798010]. [PubMed Central ID: PMC3151527]. https://doi.org/10.1136/oem.2009.052175.

  • 24.

    Dai D, Oyana TJ. Spatial variations in the incidence of breast cancer and potential risks associated with soil dioxin contamination in Midland, Saginaw, and Bay Counties, Michigan, USA. Environ Health. 2008;7(1). https://doi.org/10.1186/1476-069x-7-49.

  • 25.

    Viel JF, Clement MC, Hagi M, Grandjean S, Challier B, Danzon A. Dioxin emissions from a municipal solid waste incinerator and risk of invasive breast cancer: a population-based case-control study with GIS-derived exposure. Int J Health Geogr. 2008;7:4. [PubMed ID: 18226215]. [PubMed Central ID: PMC2267447]. https://doi.org/10.1186/1476-072X-7-4.

  • 26.

    Warner M, Eskenazi B, Mocarelli P, Gerthoux PM, Samuels S, Needham L, et al. Serum dioxin concentrations and breast cancer risk in the Seveso Women's Health Study. Environ Health Perspect. 2002;110(7):625-8. [PubMed ID: 12117637]. [PubMed Central ID: PMC1240906]. https://doi.org/10.1289/ehp.02110625.

  • 27.

    Wang SL, Chang YC, Chao HR, Li CM, Li LA, Lin LY, et al. Body burdens of polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls and their relations to estrogen metabolism in pregnant women. Environ Health Perspect. 2006;114(5):740-5. [PubMed ID: 16675430]. [PubMed Central ID: PMC1459929]. https://doi.org/10.1289/ehp.8809.

  • 28.

    Danjou AMN, Coudon T, Praud D, Leveque E, Faure E, Salizzoni P, et al. Long-term airborne dioxin exposure and breast cancer risk in a case-control study nested within the French E3N prospective cohort. Environ Int. 2019;124:236-48. [PubMed ID: 30658268]. https://doi.org/10.1016/j.envint.2019.01.001.

  • 29.

    Macon MB, Fenton SE. Endocrine disruptors and the breast: early life effects and later life disease. J Mammary Gland Biol Neoplasia. 2013;18(1):43-61. [PubMed ID: 23417729]. [PubMed Central ID: PMC3682794]. https://doi.org/10.1007/s10911-013-9275-7.